Shubham Atal
Impact in
- Pharmacology top 10%
- Piperaceae Chemical and Biological Studies
- Ginger and Zingiberaceae research
Papers in
-
- Diabetes Management and Research 5
- Diabetes Treatment and Management 5
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Balakrishnan Sadasivam (18 shared papers)Savita Vyas (2 shared papers)Rajendra Agrawal (1 shared paper)Rajnish Joshi (9 shared papers)Ratinder Jhaj (10 shared papers)Chakradhara Rao S. Uppugunduri (3 shared papers)Santenna Chenchula (5 shared papers)Avik Ray (7 shared papers)
- Journals
- International Journal of Pharmacy and Pharmaceutical Sciences (3 papers)BioDrugs (1 paper)BMJ Open (1 paper)Virology (1 paper)The International Journal of Health Planning and Management (1 paper)
- Partner nations
- IndiaUnited StatesSwitzerland
In The Last Decade
Shubham Atal
44 papers receiving 421 citations
Peers
Comparison fields: 5 of 88
- Applied Microbiology and Biotechnology 15
- Pharmacology 69
- Infectious Diseases 110
- Family Practice 7
- Endocrinology, Diabetes and Metabolism 51
Countries citing papers authored by Shubham Atal
This map shows the geographic impact of Shubham Atal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shubham Atal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shubham Atal more than expected).
Fields of papers citing papers by Shubham Atal
This network shows the impact of papers produced by Shubham Atal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shubham Atal. The network helps show where Shubham Atal may publish in the future.
Co-authors
The 23 scholars most cited alongside Shubham Atal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 116 | |
| 2 | Evaluation of the effect of piperine per se on blood glucose level in alloxan-induced diabetic mice. | 2012 | 48 |
| 3 | 2016 | 35 | |
| 4 | 2024 | 24 | |
| 5 | 2020 | 21 | |
| 6 | 2020 | 19 | |
| 7 | 2020 | 18 | |
| 8 | COST ANALYSIS OF COMMONLY USED DRUGS UNDER PRICE CONTROL IN INDIA: ASSESSING THE EFFECT OF DRUG PRICE CONTROL ORDER ON BRAND PRICE VARIATION | 2016 | 16 |
| 9 | 2019 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2020 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2024 | 6 | |
| 17 | 2015 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2023 | 5 |
About Shubham Atal
Shubham Atal is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases, Pharmacology, Epidemiology and Surgery, having authored 54 papers that have together received 438 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Diabetes Management and Research (5 papers), Diabetes Treatment and Management (5 papers), Antibiotic Use and Resistance (5 papers), Pharmaceutical studies and practices (4 papers), Metabolism, Diabetes, and Cancer (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (15 citations), Pharmacology (69 citations), Infectious Diseases (110 citations), Family Practice (7 citations) and Endocrinology, Diabetes and Metabolism (51 citations). Shubham Atal has collaborated with scholars based in India, United States and Switzerland. Frequent co-authors include Balakrishnan Sadasivam, Savita Vyas, Rajendra Agrawal, Rajnish Joshi, Ratinder Jhaj, Chakradhara Rao S. Uppugunduri, Santenna Chenchula, Avik Ray, Ankur Joshi and Sakshi Singh. Their work appears in journals such as International Journal of Pharmacy and Pharmaceutical Sciences, BioDrugs, BMJ Open, Virology and The International Journal of Health Planning and Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.